Edward P. Garvey

6.3k total citations · 1 hit paper
82 papers, 5.1k citations indexed

About

Edward P. Garvey is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Edward P. Garvey has authored 82 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 30 papers in Epidemiology and 26 papers in Molecular Biology. Recurrent topics in Edward P. Garvey's work include Antifungal resistance and susceptibility (29 papers), Fungal Infections and Studies (21 papers) and Biochemical and Molecular Research (19 papers). Edward P. Garvey is often cited by papers focused on Antifungal resistance and susceptibility (29 papers), Fungal Infections and Studies (21 papers) and Biochemical and Molecular Research (19 papers). Edward P. Garvey collaborates with scholars based in United States, United Kingdom and Japan. Edward P. Garvey's co-authors include Eric S. Furfine, Jeffrey A. Oplinger, Daniel V. Santi, Robert J. Schotzinger, Richard G. Knowles, Ferenc László, B.J.R. Whittle, William J. Hoekstra, Christopher M. Yates and C. Robert Matthews and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Edward P. Garvey

82 papers receiving 4.9k citations

Hit Papers

1400W Is a Slow, Tight Bi... 1997 2026 2006 2016 1997 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo
    1997 727 citations Edward P. Garvey, Eric S. Furfine et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward P. Garvey United States 39 1.9k 1.5k 1.3k 1.3k 727 82 5.1k
Enrico Garaci Italy 51 1.5k 0.8× 3.2k 2.1× 882 0.7× 1.7k 1.3× 280 0.4× 299 9.4k
Karl Y. Hostetler United States 50 1.4k 0.7× 3.3k 2.2× 855 0.6× 2.3k 1.8× 345 0.5× 183 7.0k
Eric S. Furfine United States 33 1.2k 0.6× 1.4k 0.9× 1.2k 0.9× 340 0.3× 595 0.8× 73 4.3k
Thomas D. Meek United States 33 1.4k 0.7× 2.9k 1.9× 1.1k 0.8× 415 0.3× 854 1.2× 70 5.3k
Mélanie Ott United States 57 2.1k 1.1× 5.3k 3.5× 1.3k 0.9× 2.1k 1.6× 172 0.2× 137 10.9k
Jacques Grassi France 54 920 0.5× 5.4k 3.6× 896 0.7× 357 0.3× 446 0.6× 206 8.9k
Kiaran Kirk Australia 51 884 0.5× 3.2k 2.1× 751 0.6× 1.0k 0.8× 549 0.8× 196 9.0k
G.M. Anantharamaiah United States 59 387 0.2× 5.3k 3.5× 893 0.7× 924 0.7× 210 0.3× 144 10.9k
Licia Tomei Italy 44 1.5k 0.8× 3.9k 2.6× 228 0.2× 2.2k 1.7× 258 0.4× 92 7.9k
Yuhuan Li China 40 488 0.3× 2.6k 1.7× 282 0.2× 1.2k 0.9× 748 1.0× 265 5.6k

Countries citing papers authored by Edward P. Garvey

Since Specialization
Citations

This map shows the geographic impact of Edward P. Garvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward P. Garvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward P. Garvey more than expected).

Fields of papers citing papers by Edward P. Garvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward P. Garvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward P. Garvey. The network helps show where Edward P. Garvey may publish in the future.

Co-authorship network of co-authors of Edward P. Garvey

This figure shows the co-authorship network connecting the top 25 collaborators of Edward P. Garvey. A scholar is included among the top collaborators of Edward P. Garvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward P. Garvey. Edward P. Garvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shubitz, Lisa F., et al.. (2017). Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs. Antimicrobial Agents and Chemotherapy. 61(5). 16 indexed citations
3.
Yates, Christopher M., Edward P. Garvey, Sammy R. Shaver, Robert J. Schotzinger, & William J. Hoekstra. (2017). Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(15). 3243–3248. 71 indexed citations
4.
5.
Shubitz, Lisa F., Hien T. Trinh, John N. Galgiani, et al.. (2015). Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models. Antimicrobial Agents and Chemotherapy. 59(12). 7249–7254. 41 indexed citations
6.
Warrilow, Andrew G. S., Claire M. Hull, Josie E. Parker, et al.. (2014). The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme. Antimicrobial Agents and Chemotherapy. 58(12). 7121–7127. 134 indexed citations
7.
Johns, Brian A., Takashi Kawasuji, Jason G. Weatherhead, et al.. (2014). Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups. Bioorganic & Medicinal Chemistry Letters. 24(14). 3104–3107. 5 indexed citations
8.
Kawasuji, Takashi, Brian A. Johns, Hiroshi Yoshida, et al.. (2013). Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles. Journal of Medicinal Chemistry. 56(3). 1124–1135. 76 indexed citations
9.
Johns, Brian A., Takashi Kawasuji, Jason G. Weatherhead, et al.. (2011). Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(21). 6461–6464. 6 indexed citations
10.
Garvey, Edward P.. (2010). Structural Mechanisms of Slow-Onset, Two-Step Enzyme Inhibition. Current Chemical Biology. 4(1). 64–73. 13 indexed citations
11.
Johns, Brian A., Jason G. Weatherhead, Scott H. Allen, et al.. (2009). The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorganic & Medicinal Chemistry Letters. 19(6). 1802–1806. 94 indexed citations
12.
Nakahara, Koichiro, Chiaki Wakasa-Morimoto, Masanori Kobayashi, et al.. (2008). Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics. Antiviral Research. 81(2). 141–146. 46 indexed citations
13.
Boros, Eric E., Brian A. Johns, Edward P. Garvey, Cecilia S. Koble, & Wayne H. Miller. (2006). Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones. Bioorganic & Medicinal Chemistry Letters. 16(21). 5668–5672. 37 indexed citations
14.
Faletto, M B, Wayne H. Miller, Edward P. Garvey, et al.. (1997). Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrobial Agents and Chemotherapy. 41(5). 1099–1107. 186 indexed citations
15.
Garvey, Edward P., Eric S. Furfine, & Paula Sherman. (1996). Purification and inhibitor screening of human nitric oxide synthase isozymes. Methods in enzymology on CD-ROM/Methods in enzymology. 268. 339–349. 10 indexed citations
16.
Arrebola, Rosalía, Alberto Olmo, Pedro A. Reche, et al.. (1994). Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.. Journal of Biological Chemistry. 269(14). 10590–10596. 32 indexed citations
17.
Garvey, Edward P., et al.. (1994). Purification and Characterization of the Constitutive Nitric-Oxide Synthase from Human Placenta. Archives of Biochemistry and Biophysics. 311(2). 235–241. 89 indexed citations
18.
Garvey, Edward P. & Thomas A. Krenitsky. (1992). A novel human phosphotransferase highly specific for adenosine. Archives of Biochemistry and Biophysics. 296(1). 161–169. 10 indexed citations
19.
Kuwajima, Kunihiro, Edward P. Garvey, Bryan E. Finn, C. Robert Matthews, & Shintaro Sugai. (1991). Transient intermediates in the folding of dihydrofolate reductase as detected by far-ultraviolet circular dichroism spectroscopy. Biochemistry. 30(31). 7693–7703. 130 indexed citations
20.
Garvey, Edward P. & C. Robert Matthews. (1989). Effects of multiple replacements at a single position on the folding and stability of dihydrofolate reductase from Escherichia coli. Biochemistry. 28(5). 2083–2093. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Garaci Breakdown of academic impact, for papers by Karl Y. Hostetler Breakdown of academic impact, for papers by Eric S. Furfine Breakdown of academic impact, for papers by Thomas D. Meek Breakdown of academic impact, for papers by Mélanie Ott Breakdown of academic impact, for papers by Jacques Grassi Breakdown of academic impact, for papers by Kiaran Kirk Breakdown of academic impact, for papers by G.M. Anantharamaiah Breakdown of academic impact, for papers by Licia Tomei Breakdown of academic impact, for papers by Yuhuan Li
Rankless by CCL
2026